LRMR Overview
Upcoming Projects (LRMR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (LRMR)
-
Discussing the Long-term Open Label Extension Study of Larimar's Nomlabofusp for Friedreich’s Ataxia
Tickers: LRMR, BIIB, RETA
Executed On: Feb 11, 2025 at 10:00 AM EST -
Discussing Reata's SKYCLARYS (omaveloxolone) post FDA approval and the potential for competing Friedrich's Ataxia therapies
Tickers: RETA, LRMR
Executed On: Mar 06, 2023 at 03:00 PM EST -
A Third Perspective: Analyzing Reata Pharma’s MOXIe study of omaveloxolone for the treatment of Friedreich's ataxia
Tickers: RETA, LRMR, DSGN
Executed On: Feb 09, 2022 at 03:00 PM EST -
A Second View: Analyzing Reata Pharma’s MOXIe study of omaveloxolone for the treatment of Friedreich's ataxia
Tickers: RETA, LRMR, DSGN
Executed On: Feb 08, 2022 at 10:00 AM EST
Upcoming & Overdue Catalysts (LRMR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (LRMR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
